Position in QURE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,136,235
+$5,370,800 QoQ
Shares Held
436,467
+491.6% QoQ
Ownership
0.692%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Jun 30, 2023CallValue
$1,719,000
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in QURE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,136,235 | 436,467 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,765,435 | 73,775 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $1,777,185 | 167,659 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $113,207 | 22,963 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $606,881 | 116,708 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $306,895 | 45,737 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,728,224 | 238,065 | Shares | Sole | 2023-08-11 | |
| 2023-06-30 | $1,719,000 | 150,000 | Call | Sole | 2023-08-11 | |
| 2023-03-31 | $9,349,330 | 464,217 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,617,078 | 291,887 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $3,183,065 | 169,673 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $1,674,449 | 89,831 | Shares | Other | 2022-08-22 | |
| 2021-12-31 | $718,371 | 34,637 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $940,773 | 29,390 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,458,148 | 79,810 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $396,261 | 11,762 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $722,238 | 19,990 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $389,771 | 10,583 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,220,393 | 71,469 | Shares | Other | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||